Keren Pharmaceutical is categorized under Commercial Biotechnical Research in New Haven, CT and active since 2004.
Keren Pharmaceutical was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact David Dreyfus at the company’s single location by writing to 488 Norton Parkway, New Haven, Connecticut CT 06511 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Keren Pharmaceutical |
Contact Person: | David Dreyfus |
Address: | 488 Norton Parkway, New Haven, Connecticut 06511 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 541711 |
Share This Business: |
Keren Pharmaceutical was started in 2004 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David Dreyfus for inquiries that concern Keren Pharmaceutical by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Keren Pharmaceutical can be found at the coordinates 41.324501,-72.942448 as well as the street address 488 Norton Parkway in New Haven, Connecticut 06511.
For its online presence, you may visit Keren Pharmaceutical’s website at and engage with its social media outlets through on Twitter and on Facebook.